Phosphorylation of the ribosomal protein S6, a marker of mTOR (mammalian target of rapamycin) pathway activation, is strongly increased in hypertrophic scars and keloids.
Swiss Tropical and Public Health Institute, Socinstr. 57, Basel, Switzerland.|University of Basel, Petersplatz 1, Basel, Switzerland.
A
A
Andreoli
Swiss Tropical and Public Health Institute, Socinstr. 57, Basel, Switzerland.|University of Basel, Petersplatz 1, Basel, Switzerland.
M T
MT
Ruf
Department of Dermatology, University Hospital, Basel, Switzerland.
P
P
Itin
Swiss Tropical and Public Health Institute, Socinstr. 57, Basel, Switzerland.|University of Basel, Petersplatz 1, Basel, Switzerland.
G
G
Pluschke
Swiss Tropical and Public Health Institute, Socinstr. 57, Basel, Switzerland.|University of Basel, Petersplatz 1, Basel, Switzerland.
P
P
Schmid
D000199:Actins / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000378:metabolism; D017439:Cicatrix, Hypertrophic / Q000378:metabolism*; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007627:Keloid / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009130:Muscle, Smooth / Q000378:metabolism; D010766:Phosphorylation / Q000502:physiology; D038601:Ribosomal Protein S6 / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism*
D000199:Actins; D015415:Biomarkers; D038601:Ribosomal Protein S6; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases